🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this exploratory, retrospective laboratory study is to asses...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-26
Trial ID
NCT02415842
Treatments Being Tested
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-08
Trial ID
NCT03275389
The purpose of the study is to characterize safety and tolerability of the ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-07-14
Trial ID
NCT05035680
This study is designed to characterize the safety and immunogenicity of a' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-09
Trial ID
NCT01059617
The purpose of this study is to assess the safety and immune response (body...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2009-08
Trial ID
NCT00943202
Treatments Being Tested
This randomized, partially-blinded, active comparator-controlled was conduc...
Status
Completed
Location
Optimal Sites
Start Date
2020-11-02
Trial ID
NCT04622592
Treatments Being Tested
The purpose of this study is to characterize the safety and immunogenicity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-01
Trial ID
NCT00985673
Treatments Being Tested
This study will evaluate the safety and immunogenicity of children previous...
Status
Completed
Location
University of Tampere Medical School, Vaccine Research Center / Tampere yliopisto rokotetutkimuskeskus
Start Date
2010-09
Trial ID
NCT01210898
Treatments Being Tested